In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

Unsupervised, at-home use of transcranial direct current stimulation (tDCS) was no better than a sham control for treating a major depressive episode, a randomized trial showed. The PSYLECT trial of ...

Let's Talk Science. Let's Talk Medicine. The leading scientific social networking website and producer of educational virtual events and webinars.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding remotely supervised transcranial direct current ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Researchers who conducted a small randomized trial of a form of non-invasive brain stimulation called tDCS (transcranial direct current stimulation) have found mechanistic evidence supporting its ...

Transcranial direct current stimulation (tDCS) provides no additional benefit when added to selective serotonin reuptake inhibitor (SSRI) therapy for adults with major depressive disorder (MDD), ...

Electroencephalography (EEG) may offer a more accessible alternative to functional magnetic resonance imaging (fMRI) for guiding transcranial direct current stimulation (tDCS) when treating aphasia.